ArticleMolecular therapy. Oncology2025

Loss of tumor suppressor circRNA CircSPINT2 drives osimertinib resistance in lung adenocarcinoma.

Rakesh Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.